SMH Begins Enrolling Healthy Adults in Experimental Antibody Trial
Coconut Telegraph
SRQ DAILY MONDAY BUSINESS EDITION
MONDAY AUG 17, 2020 |
941-917-2225
Sarasota Memorial Hospital is now enrolling healthy adults in a clinical trial testing whether an experimental antibody cocktail can prevent infection by SARS-CoV-2, the novel coronavirus that causes COVID-19. Infectious Disease specialist Manuel Gordillo, MD, principal investigator of the three monoclonal antibody trials at SMH, said the studies should prove relatively quickly whether the lab-created antibody cocktail is effective at both preventing and treating the disease. Results are expected within the next few months, possibly ahead of results from vaccine trials. “If the results replicate earlier success in laboratory tests, these antibodies have the potential to serve as an important bridge to reduce the spread of the virus and severity of the disease until a vaccine becomes available,” Dr. Gordillo said.
941-917-2225
« View The Monday Aug 17, 2020 SRQ Daily Edition
« Back To SRQ Daily Archive
